illustration of a Chinese expert working in a medicine lab

By Doug Young & Rene Vanguestaine

After several years of unbridled enthusiasm, investors have sharply pulled back their support for Chinese healthcare startups. Why the sudden cold feet toward this group? And a decade after acquiring U.S. pork giant Smithfield, China’s WH Group is eyeing a New York listing for the company. Could this be prelude to a sale of this pork barrel investment?

About China Inc

China Inc by Bamboo Works discusses the latest developments on Chinese companies listed in Hong Kong and the United States to drive informed decision-making for investors and others interested in this dynamic group of companies.

Subscribe to China Inc on your favorite app:

Apple Podcasts Spotify

Recent Articles

Lufax does finance

BRIEF: Lufax replaces chief risk officer

Online lender Lufax Holding Ltd. (LU.US; 6623.HK) on Friday announced that Youn Jeong Lim resigned as the company’s chief risk officer, citing “personal work arrangements, and was replaced by Cheng…

BRIEF: EV maker Seres launches $1.7 billion IPO

Electric vehicle (EV) maker  Seres Group Co. Ltd.  (9927.HK; 601127.SH) launched its Hong Kong IPO on Monday, aiming to sell 100 million shares for HK$131.50 apiece to raise about HK$13.2…